Press Coverage

FDA Panel Gives Exparel Thumbs Down as Regional Nerve Block

Article on the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee vote against recommending bupivacaine liposomal injectable suspension (Exparel) as a nerve block to treat regional postsurgical pain quotes ISMP’s Medical Director. For the full text of the article, please visit Medscape online.


More News

Healthcare Leaders Urged to Avoid Severity Bias, Establish Just Culture In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, the Institute for Safe Medication Practices (ISMP) is emphasizing that the focus should be